Posts Tagged ‘STEMI’
New ESC Guidelines Recommend Efient® (Prasugrel) as First-line Antiplatelet Therapy for Patients with Non-ST Segment Myocardial Infarction and Unstable Angina Acute Coronary Syndromes
Posted by: admin on: September 19, 2011
In new guidelines from the European Society of Cardiology (ESC), Prasugrel – a once daily oral antiplatelet medicine – received a Class I recommendation for use in patients undergoing percutaneous coronary intervention (PCI) after experiencing a non-ST-segment elevation acute coronary syndrome (which comprises non-ST segment elevation myocardial infarction or NSTEMI – a type of heart […]
New guidelines for treating heart attacks (heart aspirin stomach cardiac cholesterol)
Posted by: admin on: June 6, 2011
Category Cardio vascular system/ Family Practice/ Clinical guidelines We all know that as high 40% victims of 1st STEMI succumb within 1st hour. How the patient is managed is of paramount importance. More important for primary care practice is prevention of such a terminal event and following new guidelines definitely help! Team@CMHF
Search
- drchasrani: Difficult to get such a data, authenticated at that. Try Times of India online library
- rakesh pore: hi, where can i get genuine information about "10 most common drugs sold in india?" i want it for a local project
- nilesh dutta: sir, Plz give detail about MBA Sports Management Thanks and Regards
